Author

Nitya Mohan

Institute of Cancer ResearchORCID 0000-0002-8189-1399Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:mouse· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Alan A. MelcheriD· 2 shared Anton PatrikeeviD· 2 shared Emmanuel Christian PatiniD· 2 shared Joan KyulaiD· 2 shared Kevin Joseph HarringtoniD· 2 shared Malin PederseniD· 2 shared Masahiro OnoiD· 2 shared Shane FooiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intratumoural oncolytic HSV-1 reshapes the local and systemic immune landscape through CD8+ T cell reprogramming

Elizabeth S. Appleton, Anton Patrikeev, Victoria Roulstone, Mikel Portillo, Jehanne Hassan, Shane Foo, Lisa Hubbard, Joan Kyula, Isaac Dean, Ernesto López, Charleen Chan Wah Hak, Malin Pedersen, Antonio Rullan, Chanidapa Adele Tye, Mark Allen, , Alan A. Melcher

This paper shows that intratumoural oncolytic HSV-1 reprograms systemic immunity by inducing specific CD8 T cell populations that correlate with clinical response to immunotherapy.

bioRxiv · May 29, 2026 · PreprintCancer Biology

Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T cell receptor signalling.

Edward John Lloyd Armstrong, Matthew Kin-Liang Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel Christian Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, , Victoria A. Jennings

This study shows that combining oncolytic Maraba virus with PD-1 blockade overcomes resistance in advanced melanoma with a cold tumor microenvironment.

Journal for ImmunoTherapy of Cancer · Jul 1, 2024Peer-reviewedCancer Biology